Self-Reported Neuropsychiatric Post-COVID-19 Condition and CSF Markers of Neuroinflammation.

Farhadian, Shelli F; Reisert, Hailey D; McAlpine, Lindsay; Chiarella, Jennifer; Kosana, Priya; Yoon, Jennifer; Spudich, Serena

Farhadian, Shelli F; Reisert, Hailey D; McAlpine, Lindsay; Chiarella, Jennifer; Kosana, Priya; Yoon, Jennifer; Spudich, Serena.

Affiliation

Farhadian SF; Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut.
Reisert HD; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut.
McAlpine L; Department of Neurology, Yale School of Medicine, New Haven, Connecticut.
Chiarella J; Center for Brain and Mind Health, Yale University, New Haven, Connecticut.
Kosana P; Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut.
Yoon J; Department of Neurology, Yale School of Medicine, New Haven, Connecticut.
Spudich S; Department of Neurology, Yale School of Medicine, New Haven, Connecticut.

JAMA Netw Open ; 6(11): e2342741, 2023 Nov 01.

Article de En | MEDLINE | ID: mdl-37948085

This case-control study assesses cerebrospinal fluid markers of neuroinflammation and blood-brain barrier disruption in individuals with postCOVID-19 condition who reported neuropsychiatric symptoms.

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: COVID-19 / Maladies neuro-inflammatoires Limites: Humans Langue: En Journal: JAMA Netw Open Année: 2023 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google